Neoadjuvant Interleukin-12 Immunogene Therapy Protects Against Cancer Recurrence After Liver Resection in an Animal Model (Q57847200)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10767798%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Neoadjuvant interleukin-12 immunogene therapy protects against cancer recurrence after liver resection in an animal model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10767798%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

0 references

W R Jarnagin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10767798%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

K Delman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10767798%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

D Kooby

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10767798%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J Zager

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10767798%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

L H Blumgart

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10767798%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H Federoff

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10767798%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Y Fong

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10767798%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10767798%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10767798%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

231

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10767798%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10767798%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

762-771

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10767798%20AND%20SRC:MED&resulttype=core&format=json

An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology.

5 November 2019

cites work

1 reference

12 December 2020

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

1 reference

12 December 2020

Interleukin 2-dependent activation of tumor-specific cytotoxic T lymphocytes in vivo.

1 reference

12 December 2020

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

1 reference

12 December 2020

Systemic macrophage activation with liposome-entrapped immunomodulators for therapy of cancer metastasis

1 reference

12 December 2020

Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells

1 reference

12 December 2020

Regulation of human cytolytic lymphocyte responses by interleukin-12

1 reference

12 December 2020

An eosinophil-dependent mechanism for the antitumor effect of interleukin-4

1 reference

12 December 2020

Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene.

1 reference

12 December 2020

Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells

1 reference

12 December 2020

Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells

1 reference

12 December 2020

Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer

1 reference

12 December 2020

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

12 December 2020

IL-12: initiation cytokine for cell-mediated immunity

1 reference

12 December 2020

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

1 reference

12 December 2020

Gene delivery into the brain using virus vectors

1 reference

12 December 2020

Interleukin-2: its biology and clinical application in patients with cancer

1 reference

12 December 2020

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

1 reference

12 December 2020

Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo.

1 reference

12 December 2020

Immunotherapy via gene therapy: comparison of the effects of tumor cells transduced with the interleukin-2, interleukin-6, or interferon-gamma genes

1 reference

12 December 2020

1 reference

12 December 2020

Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines.

1 reference

12 December 2020

Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines.

1 reference

12 December 2020

Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and g

1 reference

12 December 2020

Surgical treatment of colorectal metastases to the liver

1 reference

12 December 2020

Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis.

1 reference

12 December 2020

Resection of colorectal liver metastases

1 reference

12 December 2020

Adjuvant chemoimmunotherapy for hepatocellular carcinoma patients. Adriamycin, interleukin-2, and lymphokine-activated killer cells versus adriamycin alone

1 reference

12 December 2020

Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector.

1 reference

12 December 2020

Rapid and efficient gene transfer in human hepatocytes by herpes viral vectors

1 reference

12 December 2020

Human Mig chemokine: biochemical and functional characterization

1 reference

12 December 2020

Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells

1 reference

12 December 2020

In situ cytokine gene transfection using vaccinia virus vectors

1 reference

12 December 2020

IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression.

1 reference

12 December 2020

Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie

1 reference

12 December 2020

Interferon gamma protects against hepatic tumor growth in rats by increasing Kupffer cell tumoricidal activity

1 reference

12 December 2020

Rapid production of interleukin-2-secreting tumor cells by herpes simplex virus-mediated gene transfer: implications for autologous vaccine production

1 reference

12 December 2020

Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer

1 reference

12 December 2020

Cytokine gene therapy of cancer using gene gun technology: superior antitumor activity of interleukin-12.

1 reference

12 December 2020

Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.

1 reference

12 December 2020

Interleukin-12 gene therapy prevents establishment of SCC VII squamous cell carcinomas, inhibits tumor growth, and elicits long-term antitumor immunity in syngeneic C3H mice

1 reference

12 December 2020

Mucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity

1 reference

12 December 2020

Impaired interleukin-12 production is associated with a defective anti-tumor response in colorectal cancer

1 reference

12 December 2020

Interleukin-12 restores dendritic cell function and cell-mediated immunity in retrovirus-infected mice

1 reference

12 December 2020

Cytokine gene therapy or infusion as treatment for solid human cancer.

1 reference

12 December 2020

Human dendritic cell (DC)-based anti-infective therapy: engineering DCs to secrete functional IFN-gamma and IL-12.

1 reference

12 December 2020

Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production

1 reference

12 December 2020

Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen)

1 reference

12 December 2020

In vivo interleukin-2 gene therapy of established tumors with herpes simplex amplicon vectors.

1 reference

12 December 2020

Adjuvant immunotherapy using fibroblasts genetically engineered to secrete interleukin 12 prevents recurrence after surgical resection of established tumors in a murine adenocarcinoma model

1 reference

12 December 2020

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases

1 reference

12 December 2020

Experimental studies of factors influencing hepatic metastases. II. Effect of partial hepatectomy

1 reference

12 December 2020

Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon

1 reference

12 December 2020

Herpes simplex virus (HSV)-mediated ICAM-1 gene transfer abrogates tumorigenicity and induces anti-tumor immunity.

1 reference

12 December 2020

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer

1 reference

12 December 2020

Efficient cotransduction of tumors by multiple herpes simplex vectors: implications for tumor vaccine production

1 reference

12 December 2020

Interferons in the treatment of human cancer

1 reference

12 December 2020

Phase I trial of recombinant interferon gamma in cancer patients

1 reference

12 December 2020

Phase I/II trial of human recombinant beta-interferon serine in patients with renal cell carcinoma.

1 reference

12 December 2020

A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons

1 reference

12 December 2020

Murine interleukin-4 displays potent anti-tumor activity in vivo

1 reference

12 December 2020

Phase I trial of recombinant human gamma-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancer

1 reference

12 December 2020

Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo

1 reference

12 December 2020

10.1097/00000658-200005000-00017

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10767798%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference